crazy leaf gip/glp-1 Are GLP-1 weight-loss drugs quietly reshaping how people eat? Could reduced appetite and smaller portion sizes change the future of food innovation? And what does this shift mean for the growing role WATCH: 4 things to know

Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials

Exploring connections between weight-loss medications and thyroid cancer: a look at the FDA adverse event reporting system database

Quick Answer: GLP-1 medications can cause heartburn in some patients, with dyspepsia and GERD reported in approximately 3-9% of users, primarily due to delayed gastric emptying that may promote acid reflux

doi: 10.1016/j.freeradbiomed.2010.12.006

While the initiating triggers vary, they converge onto conserved molecular pathways that orchestrate chromatin decondensation, nuclear membrane breakdown, and extracellular release of DNAprotein complexes [12, 51]